6MID image
Deposition Date 2018-09-19
Release Date 2019-01-16
Last Version Date 2024-10-23
Entry Detail
PDB ID:
6MID
Title:
Cryo-EM structure of the ZIKV virion in complex with Fab fragments of the potently neutralizing human monoclonal antibody ZIKV-195
Biological Source:
Method Details:
Experimental Method:
Resolution:
4.00 Å
Aggregation State:
PARTICLE
Reconstruction Method:
SINGLE PARTICLE
Macromolecular Entities
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:E protein
Chain IDs:A, C, E
Chain Length:504
Number of Molecules:3
Biological Source:Zika virus (isolate ZIKV/Human/French Polynesia/10087PF/2013)
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:M protein
Chain IDs:B, D, F
Chain Length:75
Number of Molecules:3
Biological Source:Zika virus (isolate ZIKV/Human/French Polynesia/10087PF/2013)
Polymer Type:polypeptide(L)
Molecule:monoclonal antibody ZIKV-195 heavy chain
Chain IDs:G (auth: H)
Chain Length:128
Number of Molecules:1
Biological Source:Homo sapiens
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:monoclonal antibody ZIKV-195 light chain
Gene (Uniprot):IGLV1-36
Chain IDs:H (auth: L)
Chain Length:110
Number of Molecules:1
Biological Source:Homo sapiens
Ligand Molecules
Primary Citation
Structural basis of a potent human monoclonal antibody against Zika virus targeting a quaternary epitope.
Proc. Natl. Acad. Sci. U.S.A. 116 1591 1596 (2019)
PMID: 30642974 DOI: 10.1073/pnas.1815432116

Abstact

Zika virus (ZIKV) is a major human pathogen and member of the Flavivirus genus in the Flaviviridae family. In contrast to most other insect-transmitted flaviviruses, ZIKV also can be transmitted sexually and from mother to fetus in humans. During recent outbreaks, ZIKV infections have been linked to microcephaly, congenital disease, and Guillain-Barré syndrome. Neutralizing antibodies have potential as therapeutic agents. We report here a 4-Å-resolution cryo-electron microscopy structure of the ZIKV virion in complex with Fab fragments of the potently neutralizing human monoclonal antibody ZIKV-195. The footprint of the ZIKV-195 Fab fragment expands across two adjacent envelope (E) protein protomers. ZIKV neutralization by this antibody is presumably accomplished by cross-linking the E proteins, which likely prevents formation of E protein trimers required for fusion of the viral and cellular membranes. A single dose of ZIKV-195 administered 5 days after virus inoculation showed marked protection against lethality in a stringent mouse model of infection.

Legend

Protein

Chemical

Disease

Primary Citation of related structures
Feedback Form
Name
Email
Institute
Feedback